[Click here to subscribe to our NEW weekly newsletter!!]

Saved Google Search 01/12/2003 . . . courtesy of

[Note that many of these links expire after a few weeks]

Go to Google News Home
News BETA
Preferences    Search Tips 
 
 Web 
 Images 
 Groups 
 Directory 
 News-New! 
Searched news for Paxil. (BETA)  Results 1 - 100 of about 219. Search took 0.08 seconds.
   Top Stories
   World
   U.S.
   Business
   Sci/Tech
   Sports
   Entertainment
   Health

Sort by relevance   Sorted by date

GlaxoSmithKline Tells Canada Pharmacies To Stop US Sales
Financial Express, India - 8 hours ago
... Canadian website CrossBorderPharmacy.com, for example, offers Glaxo’s best-selling
antidepressant Paxil at $127.04 for a three-month supply of 90 tablets ...

Happy Hour
Atlantic Online - 11 hours ago
... close to Dad. She says, "Here's your Sinemet and your Requip and your
potassium supplement and your Paxil, Mr. Williams.". Dad opens ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Lakeland Ledger, FL - 15 hours ago
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Charlotte Observer, NC - 15 hours ago
... YORK - A federal judge on Monday refused to grant class action status to a lawsuit
filed against GlaxoSmithKline over the marketing of its anti-depressant Paxil ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Raleigh News, NC - 15 hours ago
... AP) - A federal judge on Monday refused to grant class action status to a lawsuit
filed against GlaxoSmithKline over the marketing of its anti-depressant Paxil ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Times Daily, AL - 16 hours ago
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Miami Herald, FL - 16 hours ago
... YORK - A federal judge on Monday refused to grant class action status to a lawsuit
filed against GlaxoSmithKline over the marketing of its anti-depressant Paxil ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Sarasota Herald-Tribune, FL - 16 hours ago
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

In brief:
Contra Costa Times, CA - 17 hours ago
... A federal judge on Monday refused to grant class-action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Prognosis '03: Many More FDA Approvals
Newsday - 19 hours ago
... serotonin. In contrast, popular antidepressants, like Prozac and Paxil,
boost levels of serotonin only. Cymbalta also works faster. ADHD. ...

Drugmaker nixes border sales
Detroit Free Press, MI - 22 hours ago
... chain," he said. "Glaxo produces all their Paxil for the whole world
in Puerto Rico and ships it all over the world. To suggest ...

Optimism Among CEOs
Washington Post, DC - 13 Jan 2003
... GlaxoSmithKline, the world's second-largest drugmaker, won't face a class-action
trial over claims it misled consumers by calling the antidepressant Paxil "non ...

Paxil ad suit denied class action status
Nando Times (subscription) - 13 Jan 2003
... EST) - A federal judge on Monday refused to grant class action status to a lawsuit
filed against GlaxoSmithKline over the marketing of its anti-depressant Paxil ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
NEPA News, PA - 13 Jan 2003
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Boston.com, MA - 13 Jan 2003
... AP) A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Paxil Ad Suit Fails to Get Class Status
Lakeland Ledger, FL - 13 Jan 2003
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Federal judge rules in favor of GlaxoSmithKline in Paxil ad ...
Miami Herald, FL - 13 Jan 2003
... YORK - A federal judge on Monday refused to grant class action status to a lawsuit
filed against GlaxoSmithKline over the marketing of its anti-depressant Paxil ...

Paxil Ad Suit Fails to Get Class Status
ABC News - 13 Jan 2003
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Paxil Ad Suit Fails to Get Class Status
Miami Herald, FL - 13 Jan 2003
... YORK - A federal judge on Monday refused to grant class action status to a lawsuit
filed against GlaxoSmithKline over the marketing of its anti-depressant Paxil ...

Paxil Ad Suit Fails to Get Class Status
Newsday - 13 Jan 2003
... A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Paxil Ad Suit Fails to Get Class Status
Sarasota Herald-Tribune, FL - 13 Jan 2003
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

Glaxo warns Canadian drug sellers
CNN - 13 Jan 2003
... Canadian Web site CrossBorderPharmacy.com, for example, offers Glaxo's best-selling
antidepressant, Paxil, at $127.04 for a three-month supply of 90 tablets ...

Paxil Ad Suit Fails to Get Class Status
Times Daily, AL - 13 Jan 2003
A federal judge on Monday refused to grant class action status to a lawsuit filed
against GlaxoSmithKline over the marketing of its anti-depressant Paxil. ...

LA judge denies class action for Glaxo Paxil suit
Forbes - 13 Jan 2003
... A US judge in Los Angeles on Monday denied a request to certify as a class action
a lawsuit claiming that GlaxoSmithKline Plc's anti-depressant Paxil is habit ...

Newer Antidepressants May Increase Bleeding Risk
Reuters, UK - 13 Jan 2003
... serotonin reuptake inhibitors. SSRIs include Paxil (paroxetine),
Prozac (fluoxetine) and Zoloft (sertraline). "Our study showed ...

Glaxo Warns Canadian Cos That Thrive On US Sales
Yahoo News - 12 Jan 2003
... owner of Aptecha.com, based in Stonewall, Manitoba, said Glaxo's action "is of concern"
because the company's line includes several popular drugs, such as Paxil ...

If Everyone Were on Prozac . . .
TIME - 12 Jan 2003
Although originally approved only for adults with "symptoms of depressive illness,"
Prozac and its imitators (Zoloft, Paxil, Celexa, Luvox) are taken today by ...

TIME announces its picks for 2002
TIME - 12 Jan 2003
To be conscious in these days of Paxil, Prozac and Dr. Phil is to question
one's own sanity on an almost weekly basis. Self-diagnosis ...

The Power of Mood
TIME - 12 Jan 2003
... Antidepressant drugs like Prozac, Paxil and Zoloft, known as selective serotonin
reuptake inhibitors, or ssris, were developed to keep serotonin from being ...

'.Net' No More at Microsoft
Washington Post, DC - 10 Jan 2003
... A three-month supply of Glaxo's Paxil antidepressant sells for $127.04 on CrossBorderPharmacy.com,
an online drugstore run by Calgary-based Total Care Pharmacy ...

Antidepressants: UK panel to review suicide link
UK Comment Wire, UK - 10 Jan 2003
... In recent times, GlaxoSmithKline's top-selling product, Seroxat (Paxil in US) has
been at the center of this attention and faces several lawsuits alleging it ...

US approves Prozac for children
CBC News, Canada - 09 Jan 2003
... Prozac is part of a new class of anti-depressants called Selective Serotonin
Reuptake Inhibitors (SSRIs). Paxil and Zoloft are other SSRIs. ...

UK Probes SSRI Antidepressants
Yahoo News - 08 Jan 2003
... the safety of the selective serotonin reuptake inhibitor (SSRI) class of antidepressants
following claims that drugs such as GlaxoSmithKline's Seroxat/Paxil ...

UK Probes SSRI Antidepressants
Reuters, UK - 08 Jan 2003
... the safety of the selective serotonin reuptake inhibitor (SSRI) class of antidepressants
following claims that drugs such as GlaxoSmithKline's Seroxat/Paxil ...

Britain probes safety of antidepressant drugs
Forbes - 08 Jan 2003
... The serotonin drug class includes GlaxoSmithKline Plc's top-selling product,
Seroxat, known as Paxil in the United States, which already faces lawsuits ...

Pick up sticks: How to eat Chinese food
Providence Journal Bulletin, RI - 07 Jan 2003
... Can you help? To take the football analogy further, there's a product
that can do as much for you as Paxil did for Ricky Williams. ...

Deal gives Glaxo breathing space
Guardian, UK - 06 Jan 2003
... Glaxo scored an initial victory at the end of last year in its battle to defend
its top-selling drug, the anti-depressant Paxil, from cheaper copies. ...

Some more green stuff
Philadelphia Daily News, PA - 06 Jan 2003
... S. Broad Street. (Anxious? Stoke up on Paxil.). • Valley Green Inn,
Forbidden Drive along Wissahickon Creek. (Feast on roast falcon.). ...

Action Line
Miami Herald, FL - 06 Jan 2003
... My mother's doctor switched the alprazolam to Paxil, which the insurance paid
for, but I have to pay for the Exelon myself, and it's an expensive drug. ...

The Long Journey Back: Surviving Depression
Washington Post, DC - 05 Jan 2003
... born with. He prescribed Paxil, trying to convince himself and me
that I was suffering from social anxiety disorder. He assured ...

Market Miscellany
Daily Telegraph, UK - 04 Jan 2003
... Drugs giant GlaxoSmithKline (£12.08) reckons it can fight off attempts by rivals
to launch copycat versions of Paxil, after a US court upheld just one of four ...

Company News
Creditman, UK - 04 Jan 2003
... GLAXOSMITHKLINE was cheered by a pre-trial court decision in America that it claims
will defend Paxil, its money-spinning antidepressant, from competition by ...

Born to Be Happy, Through a Twist of Human Hard Wire
New York Times - 03 Jan 2003
... A study by Dr. Brian Knutson at the University of California at San Francisco
looked at the effects of the serotonin-enhancing antidepressant Paxil among ...

GlaxoSmithKline buys time in Paxil court case
NEPA News, PA - 03 Jan 2003
A federal judge in Philadelphia gave a mixed decision in litigation over British
drug company GlaxoSmithKline PLC's patents for anti-depressant Paxil, the ...

GlaxoSmithKline upgraded to "accumulate"
Newratings, NY - 03 Jan 2003
... in 2002. Moreover, the company lost the Augmentin patent, while another
drug, Paxil, has been challenged, says Jyske Bank. The analyst ...

SkyePharma Jumps on $120 Million Deal
ABC News - 03 Jan 2003
... for SkyePharma have brightened since last April following the successful launch
of a slow-release version of GlaxoSmithKline Plc's antidepressant Paxil CR. ...

SkyePharma Jumps on $120 Million Deal
Reuters, UK - 03 Jan 2003
... for SkyePharma have brightened since last April following the successful launch
of a slow-release version of GlaxoSmithKline Plc's antidepressant Paxil CR. ...

Born to Be Happy, Through a Twist of Human Hard Wire
New York Times - 02 Jan 2003
... A study by Dr. Brian Knutson at the University of California at San Francisco
looked at the effects of the serotonin-enhancing antidepressant Paxil among ...

Hard-wired for happiness
Toronto Star, Canada - 02 Jan 2003
... A study at the University of California looked at the effects of the serotonin-enhancing
antidepressant Paxil among normal volunteers, assigned at random to a ...

UK Outlook: Threat of war makes for an uncertain year ahead
Independent, UK - 02 Jan 2003
... to be dictated in the courtrooms of the US, particularly for GSK, which is still
fighting challenges to patents on its biggest drug, the anti-depressant Paxil ...

CORRECTED - Banks , oils inject life into FTSE 100 , GKN gains
Forbes - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this week when investors
were encouraged by a patent ruling on its top selling anti-depressant, Paxil. ...

CORRECTED - Banks , oils inject life into FTSE 100 , GKN gains
Reuters, UK - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this week when investors
were encouraged by a patent ruling on its top selling anti-depressant, Paxil. ...

Banks, oils inject life into FTSE 100, GKN gains
Forbes - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this week when investors
were encouraged by a patent ruling on its top selling anti-depressant, Paxil. ...

Banks, oils inject life into FTSE 100, GKN gains
Reuters, UK - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this week when investors
were encouraged by a patent ruling on its top selling anti-depressant, Paxil. ...

Banks help FTSE to edge higher, though GSK falls
Reuters, UK - 02 Jan 2003
... L fell two percent, retracing some of its gain earlier in the week when investors
were encouraged by a patent ruling on its top selling anti-depressant, Paxil. ...

FTSE 100 starts 2003 on weak note
Financial Times (subscription), UK - 02 Jan 2003
... Glaxo SmithKline was also hit by profit-taking after it rose sharply on Tuesday following
positive comments about the recent patent case related to Paxil, its ...

British Airways leads FTSE up but GSK slips
Reuters, UK - 02 Jan 2003
... at 1170 pence, slipping back after advances earlier in the week, when investors were
inspired by a patent ruling on its top selling anti-depressant drug Paxil. ...

Born to Be Happy, Through a Twist of Human Hard Wire
New York Times - 01 Jan 2003
... A study by Dr. Brian Knutson at the University of California at San Francisco
looked at the effects of the serotonin-enhancing antidepressant Paxil among ...

Footsie ends dismal year on high note
Financial Times (subscription), UK - 01 Jan 2003
... GlaxoSmithKline headed the buoyant blue chips following positive comment on
the recent patent case related to Paxil, its anti-depressant drug Paxil. ...

Testosterone tested as mood drug
Boston Globe, MA - 01 Jan 2003
... Psychiatrists have since abandoned such treatment for newer ideas, first electroshock
therapy and then antidepressant drugs such as Prozac and Paxil. ...

Eurostocks trims gains, US consumer confidence off
The Times of Malta, Malta - 01 Jan 2003
... reaffirmed its earnings guidance and a court ruling fuelled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil. ...

Viagra may ease antidepressant side effect
Newark Star Ledger, NJ - 31 Dec 2002
... that Viagra, Pfizer's impotence treatment, can help improve the sexual function of
men taking a class of anti-depressants that includes Prozac, Zoloft and Paxil ...

New Year's rant: The real trouble with liberals
WorldNetDaily - 31 Dec 2002
... Liberals take Paxil and Prozac and Wellbutrin so they can be mellow at all
times. Liberals have come to be synonymous with wusses and wimps. ...

Born to Be Happy, Through a Twist of Human Hard Wire
New York Times - 31 Dec 2002
... A study by Dr. Brian Knutson at the University of California at San Francisco
looked at the effects of the serotonin-enhancing antidepressant Paxil among ...

Market forces
Guardian, UK - 31 Dec 2002
... continued a recovery with a 3.9% rise as traders digested the implications of the
substantial court victory to protect its blockbuster anti-depressant, Paxil. ...

World stocks: Dow snaps 4-day losing streak
New Zealand Herald, New Zealand - 31 Dec 2002
... FTSE-100 to a positive close in thin trade and pharmaceutical giant GlaxoSmithKline
added to the cheer after a patent ruling on its anti-depressant drug Paxil. ...

ADR Report-Overseas shares wrap up 2002 on flat note
Forbes - 31 Dec 2002
... The group reaffirmed its earnings guidance and a court ruling fueled hopes it
could head off potential rivals to its antidepressant Paxil, one of its top ...

FTSE shrugs off 2002 woes to end session on upbeat note
Reuters, UK - 31 Dec 2002
... session, when GSK repeated its earnings guidance and a court ruling fuelled hopes
it could head off potential rivals to one of its top-selling drugs, Paxil. ...

Dire year ends for eurostocks, jittery 2003 looms
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil. ...

UPDATE: European Stocks Close Out 2002 In Upbeat Fashion
Yahoo Headlines - 31 Dec 2002
... chewed over the implications of GlaxoSmithKline statement Monday that it is confident
it can prevent generic competition against its depression drug Paxil. ...

Eurostocks Hold Gains, US Consumer Confidence Eyed
Morningstar Canada, Canada - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil. ...

Eurostocks Trims Gains After US Data
ABC News - 31 Dec 2002
... group reaffirmed its earnings guidance and a court ruling fueled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil ...

Eurostocks trims gains, US consumer confidence off
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil. ...

Eurostocks Trims Gains After US Data
Reuters, UK - 31 Dec 2002
... group reaffirmed its earnings guidance and a court ruling fueled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil ...

Judge splits decision in Glaxo case
Philadelphia Business Journal, PA - 31 Dec 2002
... District Court judge in Philadelphia rendered a split decision Monday in a patent
dispute involving GlaxoSmithKline's top-selling drug, the antidepressant Paxil ...

Eurostocks hold gains, US consumer confidence eyed
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled hopes it could head
off potential rivals to one of its top-selling drugs, anti-depressant Paxil. ...

European Stocks Close Out 2002 In Upbeat Fashion
Yahoo Headlines - 31 Dec 2002
... chewed over the implications of GlaxoSmithKline statement Monday that it is confident
it can prevent generic competition against its depression drug Paxil. ...

Decision Is Mixed in Paxil Patents Case
Newsday - 31 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over British drug
company GlaxoSmithKline PLC's patents for anti-depressant Paxil, the company ...

FTSE shrugs off 2002 woes to end session on upbeat note
Forbes - 31 Dec 2002
... session, when GSK repeated its earnings guidance and a court ruling fuelled hopes
it could head off potential rivals to one of its top-selling drugs, Paxil. ...

FTSE ends higher on last day of 2002; GSK strong
Forbes - 31 Dec 2002
... giant GlaxoSmithKline closed 3.9 percent up as it continued to benefit from hopes
that it would successfully fend off rivals to its blockbuster drug Paxil. ...

Apotex loses Paxil court case
National Post, Canada - 31 Dec 2002
... criticized what it called outdated drug laws after a US judge upheld a key patent
on anti-anxiety drug Paxil, a ruling that prevents Apotex from launching its ...

Glaxo wins partial victory in patent battle
icWales, UK - 31 Dec 2002
DRUGS giant GlaxoSmithKline claimed a partial victory in its battle to prevent
the launch of generic competition to its key Paxil treatment yesterday. ...

Dow climbs 29, Nasdaq falls 8
Baltimore Sun, MD - 31 Dec 2002
... A US federal judge ruled in favor of the second-largest drugmaker, which is
seeking to fend off cheaper competitors to its $3 billion-a-year Paxil. ...

GSK wins a legal round
Raleigh News, NC - 31 Dec 2002
RESEARCH TRIANGLE PARK -- GlaxoSmithKline has scored a tactical victory against generic
versions of its blockbuster anti-depressant Paxil, a legal battle that ...

Meadowbrook, Rouge lead gains
Detroit News, MI - 30 Dec 2002
... won US regulatory approval for its migraine medicine and one of GlaxoSmithKline
Plc's patents for its Paxil antidepressant received protection from a US ...

Daily Briefing
The News Journal, DE - 30 Dec 2002
A federal judge gave a mixed decision in litigation over British drug
company GlaxoSmithKline PLC's patents for anti-depressant Paxil. ...

Gannett, Lilly, Celadon lift state equity index
Indianapolis Star, IN - 30 Dec 2002
... Philadelphia -- A federal judge gave a mixed decision in litigation over British
drug company GlaxoSmithKline PLC's patents for antidepressant Paxil, the ...

Apotex gets split decision on patent
Toronto Star, Canada - 30 Dec 2002
has emerged with a split decision in an American patent case against
Glaxo-SmithKline Inc. over the anti-depression drug Paxil. ...

Apotex wins small victory against Glaxo
The Globe and Mail, Canada - 30 Dec 2002
... won a small victory yesterday in its legal bid to sell a generic version of the
anti-depressant drug Paxil, after a US judge ruled against British drug giant ...

Banks nudge TSX back into black
The Globe and Mail, Canada - 30 Dec 2002
... won US regulatory approval for a migraine medicine and a US judge upheld one of GlaxoSmithKline
PLC's patents for the antidepressant Paxil, its biggest seller. ...

Born to Be Happy, Through a Twist of Human Hard Wire
New York Times - 30 Dec 2002
... A study by Dr. Brian Knutson at the University of California at San Francisco
looked at the effects of the serotonin-enhancing antidepressant Paxil among ...

Decision Is Mixed in Paxil Patents Case
Newsday - 30 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over British drug
company GlaxoSmithKline PLC's patents for anti-depressant Paxil, the company ...

Decision Is Mixed in Paxil Patents Case
Yahoo Headlines - 30 Dec 2002
LONDON - A federal judge gave a mixed decision in litigation over British drug
company GlaxoSmithKline PLC's patents for anti-depressant Paxil, the company ...

Decision Is Mixed in Paxil Patents Case
ABC News - 30 Dec 2002
A federal judge gave a mixed decision in litigation over British drug company GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company said Monday. ...

PRESS DIGEST - Wall Street Journal - Dec 31
Forbes - 30 Dec 2002
... GlaxoSmithKline said it is confident it can prevent generic competition to its
depression drug Paxil, despite a mixed initial verdict in its legal case ...

Glaxo protects Paxil patent, thwarting generic rivals
Pittsburgh Tribune Review, PA - 30 Dec 2002
LONDON — GlaxoSmithKline Plc said a US judge upheld one of its patents for Paxil,
helping the world's second-biggest drugmaker fend off cheaper competitors ...

OPEC May Increase Supplies
Washington Post, DC - 30 Dec 2002
Pharmacist Donald Tierney displays Paxil in his drugstore in Wilmette,
Ill., yesterday. A federal judge has upheld one of GlaxoSmithKline's ...



1

2

3

Next



Google Home - Advertise with Us - Search Solutions - Services & Tools - Jobs, Press, & Help

©2003 Google
L10 Web Stats Reporter 3.1 L10 Hit Counter - Free Web Statistics
LevelTen Web Design - Flash, Website Designers